KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Equity Ratio: 2011-2025

Historic Equity Ratio for Sarepta Therapeutics (SRPT) over the last 14 years, with Sep 2025 value amounting to 0.38.

  • Sarepta Therapeutics' Equity Ratio rose 11.41% to 0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38, marking a year-over-year increase of 11.41%. This contributed to the annual value of 0.39 for FY2024, which is 46.44% up from last year.
  • According to the latest figures from Q3 2025, Sarepta Therapeutics' Equity Ratio is 0.38, which was up 2.44% from 0.37 recorded in Q2 2025.
  • Sarepta Therapeutics' Equity Ratio's 5-year high stood at 0.39 during Q4 2024, with a 5-year trough of 0.12 in Q4 2022.
  • Over the past 3 years, Sarepta Therapeutics' median Equity Ratio value was 0.31 (recorded in 2024), while the average stood at 0.31.
  • In the last 5 years, Sarepta Therapeutics' Equity Ratio crashed by 58.26% in 2022 and then skyrocketed by 113.92% in 2023.
  • Over the past 5 years, Sarepta Therapeutics' Equity Ratio (Quarterly) stood at 0.29 in 2021, then plummeted by 58.26% to 0.12 in 2022, then skyrocketed by 113.92% to 0.26 in 2023, then skyrocketed by 46.44% to 0.39 in 2024, then climbed by 11.41% to 0.38 in 2025.
  • Its Equity Ratio stands at 0.38 for Q3 2025, versus 0.37 for Q2 2025 and 0.33 for Q1 2025.